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Background: Interleukin (IL)-18 is an important regulator of innate and acquired immune responses and has
multiple roles in chronic inflammation and autoimmune disorders. Obesity is characterized by low- grade chronic
inflammation. IL-18 has been suggested as an adipogenic cytokine that is associated with excess adiposity. The
purpose of this study is to evaluate the relationship between IL-18 gene polymorphisms (−137 G/C and −607 C/A)
and obesity.
Methods: All 680 subjects were genotyped for the polymorphisms of IL-18 gene promoters (at positions −137 G/C
and −607 C/A) using a polymerase chain reaction (271 cases with BMI ≥25 kg/m2 and 409 controls with BMI
<25 kg/m2). A chi-square test was used to compare the genotype and allele frequencies between the cases and
control populations.
Results: Analyses of the genotype distributions revealed that IL-18 –607 C/A polymorphism was associated with an
increase in body mass index in obese women in the Korean population (chi(2) = 12.301, df= 2, p= 0.015).
Conclusion: Carriage of the A allele at position −607 in the promoter of the IL-18 gene may have a role in the
development of obesity.
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Obesity is increasing rapidly among women all over the
world, and more women in fertile ages become overweight
and obese [1]. Among all other problems, women who are
obese have higher rates of amenorrhoea and infertility [1].
Over the past decade, research has associated obesity with
inflammation; this association was first proposed in the
seminal article by Hatamilsligil et al. [2]. In this article,
tumor necrosis factor-α (TNF-α) was shown to be consti-
tutively expressed via adipose tissue, to be hyperexpressed
in obesity, and to mediate insulin resistance in the major
animal models of obesity. Furthermore, the neutralization
of TNF-α with soluble TNF-α receptors resulted in the
restoration of insulin sensitivity [2]. Thus, obesity is now
characterized by a state of low- grade inflammation that is
associated with the increase of cytokine production.* Correspondence: jyum@khu.ac.kr
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reproduction in any medium, provided the orAdipose tissue, which is infiltrated by monocytes and
macrophages in obesity, secretes numerous soluble media-
tors including adipokines such as adiponectin or leptin
and many classical cytokines such as TNF-α, interleukin
(IL)-6, and IL-1 family members [3,4].
IL-18 has been suggested as an adipogenic cytokine [5]
that is associated with excess adiposity [6]. Adipocytes
from obese individuals produce higher levels of IL-18
compared with lean individuals and higher circulating
IL-18 levels were observed in obese individuals and
those with a high body mass index (BMI), insulin resist-
ance, hypertriglyceridemia, and metabolic syndrome [6-9].
Deficiencies of IL-18 in mice (Il18−/−) led to the exhibition
of late- onset obesity and insulin resistance [10]. There-
fore, it has been hypothesized that the increased IL-18
concentrations have a pathophysiological role in obesity
and metabolic syndromes.
Obesity has a strong genetic etiology involving numerous
identified metabolic pathways and others not yet examined.
IL-18 promoter polymorphisms have been associated with. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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polymorphisms (SNPs) in the promoter of the IL-18 gene
at the positions −656 G/T, −607 C/A and −137 G/C have
been identified. The functional significance of the two
SNPs of the C allele at position −607 and the G allele at
position −137 is attributed to the higher transcription and
protein production of IL-18 [11,12]. In order to investigate
the possible roles of the SNPs from the IL-18 gene
promoter region (−137 G/C and −607 C/A) in the
development of obesity, the genetic polymorphisms of
obese subjects were evaluated.
Methods
Subjects
Subjects were recruited consecutively from an obesity
clinic at a Korean hospital; they were placed into an
ongoing project that investigates candidate genes for
obesity among the Korean population. The present study
population included 680 individuals: 271 were chosen as
cases (BMI ≥25 kg/m2) and 409 were chosen as controls
(BMI <25 kg/m2). The 271 cases (BMI ≥25 kg/m2)
consisted of 170 female subjects and 101 male subjects.
All cases were nonsmokers and had no evidence of cancer,
liver, renal, hematological disease or other metabolic
disorders other than obesity. Details of the recruitment,
body composition assessment, and biochemical analysis
have been described previously [13]. All participants gave
informed consent prior to participating in the research,
which was approved by the local ethics committee in
accordance with the Helsinki Declaration. Some subjects
had participated in the research reported previously [13].
Phenotype measurements
Anthropometry
Height (in cm) and weight (in kg) were measured in order
to calculate the BMI as weight (kg)/height (m) squared.
The waist circumference (measured at the narrowest point
above the hip) was divided by the circumference of theTable 1 Sequence-specific primers for G/C and C/A alleles and
the promoter of the IL-18 gene
Sequence-specific Primers Primer sequence
G/C allele at position −137
Common reverse primer 5’–AGGAGGGCAA
forward primers 1 5’–CCCCAACTTTT
forward primers 2 5’–CCCCAACTTTT
Control forward primer 5’–CCAATAGGACT
C/A allele at position −607
Common reverse primer 5’–TAACCTCATTC
forward primers 1 5’–GTTGCAGAAAG
forward primers 2 5’–GTTGCAGAAAG
Control forward primer 5’–CTTTGCTATCAhip (measured at its greatest gluteal protuberance) in
order to obtain the waist-to-hip ratio (WHR).
Dual-energy X-ray absorptiometry
The fat mass was determined using dual energy X-ray
absorptiometry.
Genotyping
Genomic DNA was extracted from peripheral blood
samples using the ExgeneTM Blood SV Kit (GeneAll,
Korea) as per the manufacturer’s instructions. The
concentration of DNA was estimated via absorbance at
260 nm. The SNPs were noted at position −137 (G/C)
and −607 (C/A) in the promoter region of the IL-18
gene, located at chromosome 11q22.2-q22.3. For the
position −137-specific PCR, a common reverse primer
and two sequence- specific forward primers were used
to amplify the 261-bp product. A control forward primer
was used to amplify the 446-bp fragment covering the
polymorphic site as an internal positive amplification
control. PCR was performed in a 20 μl volume containing
0.5 μM of one sequence specific primer and −137 R,
0.3 μM of −137 CTRL, 20 mM Tris–HCl (pH 8.4),
50 mM KCl, 1.5 mM MgCl2, 200 μM/dNTPs, 1 U of Taq
DNA polymerase, and 200 ng genomic DNA. The cycling
conditions were 2 min at 94°C, followed by 5 cycles of
20 s at 94°C and 60 s at 67°C and 25 cycles of 20 s at 94°C,
20 s at 61°C and 40 s at 72°C [14].
For the position −607-specific PCR, a common reverse
primer and two sequence- specific forward primers were
used to amplify the 196-bp product. A control forward
primer was used to amplify the 301-bp fragment covering
the polymorphic site as an internal positive amplification
control. PCR was performed in a 20 μl volume containing
0.4 μM of one sequence specific primer and −607 R,
0.13 μM of −607 CTRL, 20 mM Tris–HCl (pH 8.4),
50 mM KCl, 1.5 mM MgCl2, 200 μM/dNTPs, 1 U of Taq










Table 2 Characteristics of obese subjects according to
BMI
BMI (kg/m2) pa
25 ~ 26.9 27 ~29.9 ≥ 30
Age (year) 28.9 ± 11.2 31.3 ± 10.54 33.1 ± 12.9 .123
Weight (kg) 64.7 ± 4.7 71.3 ± 6.2 84.5 ± 12.9 < 0.001
Height (cm) 158.3 ± 5.9 159.0 ± 5.9 160.8 ± 5.6 .029
Total cholesterol (mg/dL) 184.3 ± 46.0 184.2 ± 36.6 189.0 ± 40.4 .728
Triglyceride (mg/dL) 117.0 ± 112.4 110.3 ±70.7 136.3 ± 112.8 .251
Fat mass (kg) 23.3 ± 2.3 26.6 ± 2.9 36.4 ± 8.1 < 0.001
PBF (%) 36.1 ± 2.7 37.0 ± 5.0 41.9 ± 4.3 < 0.001
WHR 0.89 ± 0.03 0.92 ± 0.03 0.99 ± .07 < 0.001
Values are means ± S.D.
BMI=body mass index, PBF= percentage of body fat, WHR=Waist-to-hip ratio.
aBy one-way Anova analysis (among BMI groups).
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20 s at 94°C, 40 s at 64°C, and 40 s at 72°C, and 25 cycles
of 20 s at 94°C, 40 s at 57°C, and 40 s at 72°C [14]. All
PCR products were separated in 2% agarose gels stained
with ethidium bromide. The sequence- specific primers
for the position −137 and −607- specific PCR are listed on
Table 1.
Statistical analysis
A χ2 test was used to compare the genotype and allele
frequencies between the cases and control populations.
All statistical analyses were performed using SPSS v17.00
(SPSS Inc.) statistical analysis software. Hardy-Weinberg
equilibrium was tested by chi-squared test and the haplo-
type analyses were done using HapAnalyzer version 1.0
(http://hap.ngri.go.kr). The associations between allele
frequencies of SNPs and cases were estimated by comput-
ing the odds ratios and their 95% confidence intervals with
logistic regression analyses controlling for age. Genetic
Power Calculator (http://pngu.mgh.harvard.edu/~purcell/
gpc) [15] was used to compute the statistical power of our
sample. A p- value of less than 0.05 was considered statis-
tically significant.
Results
Clinical characteristics of subjects according to BMI
The clinical characteristics of the cases according to their
BMI are listed in Table 2. In order to obtain a better separ-
ation between phenotypes, the subjects were divided
into three BMI groups: moderately overweight (BMI
25~26.9 kg/m2), severely overweight (BMI 27~29.9 kg/m2),
and obese (BMI ≥30 kg/m2). As expected, the total
cholesterol, triglyceride, fat mass, percentage of body
fat (PBF), and WHR increased in proportion to the
BMI values.Table 3 Genotype frequencies of IL-18 gene promoter polymo
Cases (BMI ≥25),n (%)













a By χ2-test (2-sided).Allele and haplotype frequencies in obese cases and
controls
The genotype and allele frequencies for IL-18 polymorphisms
are summarized in Table 3. The genotype frequencies
were in agreement with the Hardy-Weinberg equilibrium.
The power of the sample size was calculated to verify
our data using a genetic power calculator [15]. The
sample powers of the SNPs were more than 95%
(α = 0.05, genotype relative risk = 2-fold). For the −137
genotypes from the 271 cases with BMI ≥25 kg/m2, 208
had the GG type (76.8%), 56 the GC type (20.7%), and
7 the CC type (2.6%) genotypes. Of the 409 controls
with BMI <25 kg/m2, 290 had the GG type (70.9%), 110
the GC type (26.9%), and 9 the CC type (2.2%) genotypes.
Regarding the −607 genotypes, 69 of the 271 cases with
BMI ≥25 kg/m2 had the CC type (25.5%), 157 the CA
type (57.9%), and 45 the AA type (16.6%) genotypes. 94
of the 409 controls with BMI <25 kg/m2 were type CCrphism of 271 cases and 409 controls
Controls (BMI <25),n (%) χ2 pa
290 (70.9) 3.455 .178
110 (26.9)
9 (2.2)
690 (84.4) 1.957 .162
128 (15.6)
94 (23.0)
231 (56.5) 1.807 .405
84 (20.5)
419 (51.2) 1.343 .246
399 (48.8)
Table 4 Haplotype frequencies of IL-18 gene promoter polymorphism in case alleles and control alleles
Haplotype −607 C/A −137 G/C Cases (BMI ≥25),n (%) Controls (BMI <25),n (%) χ2 pa
I C G 301 (55.5) 412 (50.4) 3.491 .062
II C C 0 (0) 5 (0.6) 3.325 .068
III A G 182 (33.6) 284 (34.7) 0.188 .665
IV A C 59 (10.9) 117 (14.3) 3.380 .066
Total 542 818
a By χ2-test (2-sided).
Table 5 Frequencies of IL-18 gene promoter
polymorphism according to BMI in female cases with BMI
≥25 kg/m2 (n= 170)
BMI (kg/m2) χ2 pa
25 ~26.9, n (%) 27~ 29.9, n (%) ≥ 30, n (%)
Position −137 34 (75.6) 52 (76.5) 44 (77.2) 1.212 .876
genotype
GG
GC 9 (20.0) 15 (22.1) 12 (21.1)
CC 2 (4.4) 1 (1.5) 1 (1.8)
Position −607 12 (32.4) 20 (27.4) 10 (16.7)
genotype
CC
CA 22 (59.5) 45 (61.6) 32 (53.3) 12.301 .015
AA 3 (8.1) 8 (11.0) 18 (30.0)*,†
a By χ2-test (2-sided), among three BMI subgroups.
* By χ2-test (2-sided), p= 0.021, BMI 25 ~ 26.9 kg/m2 group versus BMI ≥30 kg/m2
group.
† By χ2-test (2-sided), p= 0.017, BMI 27 ~ 29.9 kg/m2 group versus BMI ≥30 kg/m2
group.
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genotypes. No significant differences were observed in
the genotype distribution or allele frequency between
the cases and controls.
The haplotype frequencies were estimated based on
genotypes of the IL-18 polymorphisms. The four haplotyes
(haplotype I, II, III, and IV) of the IL-18 promoter at
positions −607 and −137 were present in both cases
(BMI ≥25 kg/m2) and controls (BMI <25 kg/m2) and
are presented in Table 4. The frequencies of haplotypes
I, II, III, and IV in the cases were 55.5%, 0%, 33.6%, and
10.9%, respectively. The frequencies of haplotypes I, II,
III, and IV in the controls were 50.4%, 0.6%, 34.7%, and
14.3%, respectively. No significant differences were
observed in the haplotype frequencies between the
cases and the controls.
Relationship between IL-18 polymorphism and BMI seen
in obese women
In order to further evaluate the association between the
IL-18 polymorphisms and BMI, only female subjects, 170
of the 271 cases with BMI ≥25 kg/m2, were grouped
according to their BMI range. The distributions of the
GG, GC, and CC genotypes of position −137 and the
distributions of the CC, CA, and AA genotypes of position
−607 in these cases are shown in Table 5. A significant
difference was found in the −607 C/A genotype distribu-
tion among the BMI subgroups (χ2 = 12.301, df=2,
p= 0.015). Further analysis showed that the frequency of
position −607 AA genotype was higher in a subgroup
with BMI ≥30 kg/m2 than in both moderately over-
weight (BMI 25 ~ 26.9 kg/m2) and severely overweight
(BMI 27 ~ 29.9 kg/m2) groups (χ2 = 7.729, df= 2,
p = 0.021 and χ2 = 8.182, df = 2, p= 0.017, respectively).
However, a difference in the distributions of the position
−137 between BMI subgroups was not observed in the
obese women.
Discussion
This study determined whether the promoter polymorphisms
of IL-18 gene were associated with obesity and an-
thropometric parameters in obese women. Obesity is a
complex metabolic disorder with a strong genetic com-
ponent [16]. There are many candidate genes forobesity and its related phenotypes [16]. Most of these
genes are candidates for obesity because their muta-
tions cause rare genetic syndromes that affect the
adipocyte differentiation [17]. However, the association
between inflammatory cytokine genes and obesity has
been studied less frequently when compared with other
candidate genes. Thus, the association between the
polymorphism of IL-18, a member of the IL-1 family,
and obesity without metabolic disease was a primary
focus of this study.
In this study, an association between the polymorph-
ism in the IL-18 gene and BMI in women was found.
The frequency of haplotype I, which has the C allele at
position −607 and the G allele at position −137, was
higher in the subjects with BMI ≥25 kg/m2 than in the
control subjects with BMI <25 kg/m2, although the stat-
istical significance was marginal. In addition, there was
an apparent association between the −607 C/A poly-
morphism in IL-18 and obesity in women.
The functional significance of the two SNPs of the C
allele at position −607 and the G allele at position −137
is attributed to the higher transcription and protein
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here, it was observed that the frequency of haplotype I
(the C allele at position −607 and the G allele at position
−137) in the cases with BMI ≥25 kg/m2 was higher than
that in the controls with BMI <25 kg/m2. Therefore, it
can be inferred that the mechanism by which the IL-18
gene polymorphism might influence obesity is related to
different IL-18 synthesis, secretion, and activity. Indeed,
several studies have shown elevated circulating IL-18
concentrations in subjects with obesity and insulin resistance
[6,18-20]. In addition, serum IL-18 was increased in obese
women, and it declined as body weight was lost [21].
The human IL-18 gene is located on chromosome
11q22.2-q23.3. Three SNPs in the promoter of the IL-18
gene at positions −656 G/T, −607 C/A and −137 G/C
have been identified. These promoter SNPs have been
implicated as susceptibility loci for various diseases,
including asthma [22], pulmonary tuberculosis [23],
inflammatory bowel disease [24], Parkinson’s disease
[25], polycystic ovary syndrome [26], type I diabetes
[27], and allergic disorders [28].
It now appears that obesity is associated with a low-
grade inflammation of the white adipose tissue resulting
from the chronic activation of the innate immune
system as the IL-1 family. Until recently, there were four
members of the IL-1 family: IL-1α, IL-1β, IL-1 receptor
antagonist (IL-1ra), and IL-18 [29]. Previous studies have
described an association between the IL-1 family gene
polymorphism and obesity. Manica-Cattani et al. [30]
and Lee et al. [16] reported that IL-1β polymorphism
(+3953 C/T) is linked to the development of obesity.
Song et al. [31] also suggested that IL-1α polymorphism
(−889 C/T) is associated with obesity in women. In
addition, Strandberg et al. [32,33] demonstrated that the
IL-1 system gene polymorphisms are associated with fat
mass in men. The present study is the first approach in
exploring the role of the IL-18 gene promoter poly-
morphism in the etiology of obesity in the Korean popu-
lation. In addition, obesity is increasing rapidly among
women all over the world. Obese women have a higher
risk than nonobese women of infertility and pregnancy.
The loss of as little as 5% of body weight is accompanied
by an increase in ovulation rates and reduces biochem-
ical abnormalities [34]. Therefore, the present study
might allow targeted therapies to be developed to
improve reproductive health in obese women.
Conclusions
In the present study, two polymorphisms in the promoter
regions of the IL-18 gene were identified. An association
between the −607 C/A polymorphism and BMI were
demonstrated in women. The results suggest that the
−607 C/A polymorphism of the IL-18 gene may have a
role in the development of obesity.Competing interests
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